U.S. Biomaterials Market to Surpass USD 171.3 Billion by 2030 Driven by Advanced Regenerative Solutions

The U.S. biomaterials market, valued at USD 59.3 billion in 2023, is projected to grow at a strong CAGR of 14.8% from 2024 to 2030, reaching an estimated USD 171.3 billion by 2030, according to DataM Intelligence. This accelerated growth is driven by rising incidences of chronic diseases, increased accidental injuries, and heightened demand for tissue engineering and regenerative medicine applications. Biomaterials-ranging from metallic and polymeric to natural and ceramic types-have become essential in developing implants, prosthetics, and advanced medical devices across multiple disciplines, including orthopedics, dentistry, cardiovascular, and plastic surgery.

Innovations in nanotechnology, intelligent biomaterials, and medical 3D printing are transforming the healthcare sector, enabling improved tissue repair, organ replacement, and targeted drug delivery. The integration of biomaterials into diagnostic systems, bioimaging, and regenerative therapies is further strengthening the market's position in the U.S., which represents over one-third of the global biomaterials industry.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/biomaterials-market?utm_source=OpenPR&utm_campaign=Onkar

Key Highlights from the Report

➤ The U.S. biomaterials market is expected to grow at a CAGR of 14.8% through 2030.
➤ Metallic biomaterials held the largest share of 40.2% in 2023, driven by orthopedic and dental implants.
➤ Natural biomaterials are forecasted to grow at the fastest CAGR of 18.2%.
➤ Orthopedic applications dominated with a 25.2% market share in 2023.
➤ Plastic surgery represents the fastest-growing application segment at 18.0% CAGR.
➤ Technological advancements in 3D printing and nanotechnology are shaping industry growth.

Market Segmentation

By Product Type:
Metallic biomaterials led the market in 2023 due to their widespread use in durable, load-bearing implants for joint, dental, and reconstructive applications. They offer superior strength, biocompatibility, and corrosion resistance ideal for orthopedic surgeries such as hip or knee replacements. Conversely, natural biomaterials are expected to grow at an impressive 18.2% CAGR owing to their biocompatibility, biodegradability, and enhanced adaptability for tissue regeneration, making them vital in the development of artificial tissues and organs.

By Application:
The orthopedic segment accounted for 25.2% of the total market in 2023, supported by a rapidly aging population and the rising incidence of musculoskeletal disorders. These biomaterials, evolving across three generations-from bioinert to bioactive and now molecularly responsive types-are driving orthopedic implant innovation. Meanwhile, plastic surgery is projected to grow at 18.0% CAGR over the forecast period. The use of biomaterials in cosmetic and reconstructive procedures, including tissue fillers, acellular dermal matrices, and craniofacial implants, continues to rise in response to increasing demand for minimally invasive solutions and aesthetic enhancement.

Regional Insights
The U.S. remains the dominant contributor to the global biomaterials landscape, accounting for over 33.3% of total market share in 2023. This leadership is supported by advanced healthcare infrastructure, high healthcare expenditure, and continuous funding in life sciences innovation. The country's robust aging population and rising orthopedic and plastic surgery procedures have accelerated domestic demand for next-generation biomaterials.

Technological innovation across U.S.-based firms is fueling product performance, focusing heavily on 3D printing, nanomaterial integration, and customizable solutions for regenerative medicine. The adoption of biomaterials in bioengineering, drug delivery, and diagnostic fields is expanding rapidly, enhancing both adoption rates and patient outcomes.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/biomaterials-market?utm_source=OpenPR&utm_campaign=Onkar

Market Dynamics

Market Drivers:
Rising incidences of chronic and degenerative diseases, combined with higher demand for orthopedic and reconstructive surgeries, are boosting biomaterial applications. Growing usage in tissue engineering, nanotech-enabled therapies, and 3D printing further strengthens market expansion.

Market Restraints:
Regulatory complexities, stringent FDA requirements for biocompatibility and labeling, and the high cost of clinical validation pose adoption challenges. Post-market safety surveillance adds additional compliance burdens, particularly for emerging innovators.

Market Opportunities:
Increasing research funding in regenerative medicine, the adoption of smart biomaterials for real-time physiological responses, and growing adoption of biodegradable implants present lucrative opportunities. Developments in piezoelectric scaffolds, polymeric nanostructures, and 3D-printed organ models will define the next generation of personalized care solutions.

Purchase This Exclusive Report at Just USD 6072 Only: https://www.datamintelligence.com/buy-now-page?report=biomaterials-market?utm_source=OpenPR&utm_campaign=Onkar

Reasons to Buy the Report

✔ Gain comprehensive insights into key market drivers, restraints, and opportunities.
✔ Access detailed segmentation covering product types, applications, and regional growth.
✔ Understand the competitive strategies shaping biomaterial innovation and M&A activities.
✔ Stay informed on FDA regulatory updates impacting medical-grade biomaterials.
✔ Evaluate technological trends in medical 3D printing, smart materials, and regenerative applications.

Frequently Asked Questions (FAQs)

◆ How Big is the U.S. Biomaterials Market in 2025?
◆ Which Product Type Leads the U.S. Biomaterials Market in 2023?
◆ What is the Projected Growth Rate of the Market Through 2030?
◆ Which Application Segment Is Expected to Show the Highest CAGR?
◆ Who Are the Key Players Operating in the U.S. Biomaterials Market?

Company Insights

Medtronic plc

Evonik Industries AG

Carpenter Technology Corporation

Invibio Ltd.

Zimmer Biomet Holdings, Inc.

BASF SE

Covalon Technologies Ltd.

Stryker

Johnson & Johnson

Corbion

Collagen Matrix, Inc.

Berkeley Advanced Biomaterials

Recent Developments:

In October 2023, Evonik launched VESTAKEEP iC4612 3DF and iC4620 3DF, the first carbon-fiber-reinforced PEEK filaments for 3D-printed implants, offering higher flexibility and mechanical resilience.

In September 2023, BASF introduced bio-based 2-octyl acrylate featuring 73% 14C-traceable renewable content, demonstrating a sustainable approach to medical adhesive solutions.

In January 2023, Zimmer Biomet announced the acquisition of Embody, Inc. for up to USD 275 million, expanding its regenerative soft tissue product portfolio.

In April 2023, Novo Nordisk partnered with Aspect Biosystems to develop bioprinted biomaterial-based tissue therapies for metabolic disorders.

Conclusion

The U.S. biomaterials market is entering a transformative era marked by technological breakthroughs, sustainability initiatives, and a surge in regenerative and reconstructive medical applications. As clinical innovation converges with advanced manufacturing techniques such as 3D printing and AI-enabled material design, the market is poised for sustained long-term expansion. Key players are increasingly investing in R&D, strategic collaborations, and eco-friendly alternatives, ensuring continuous advancement of biocompatible materials that are revolutionizing patient recovery and treatment outcomes in modern medicine.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.